Embecta's compelling ~44% free cash flow yield offers a strong risk-reward despite headwinds from new insulin technologies ...

Embecta Corporation (($EMBC)) has held its Q1 earnings call. Read on for the main highlights of the call. Embecta Corporation’s recent earnings ...

Embecta Corp. (NASDAQ:EMBC) announced that its Annual Meeting of Stockholders, which took place on Monday, resulted in the ...

Chief Executive Officer of embecta. "We remain on track to complete the restructuring plan associated with the discontinuation of the insulin patch pump progr PARSIPPANY, N.J., Feb. 06 ...

Chief Executive Officer of embecta. "We remain on track to complete the restructuring plan associated with the discontinuation of the insulin patch pump program by the end of the first half of the ...

However, Embecta announced the discontinuation of its insulin patch pump program due to high investment costs and competitive pressures. On the personnel front, Embecta Corp. announced the ...

Welcome, ladies and gentlemen, to the Embecta Fiscal First Quarter 2025 ... our decision this past November to discontinue our insulin patch pump program, initiate a restructuring plan intended ...

23, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its ...